Friday, 16 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

IR NCP STF Stock Plummets 28% In Recent Sessions

Loading stream...

(VIANEWS) - BANK OF IRELAND NCP STF (ISEQ All Share: DD7D.IR) saw its share price significantly decrease over the past 10 sessions, falling 28.26% from EUR23 to EUR16.50 by 14:29 EST on Tuesday - this following five consecutive losses that led to overall performance being down on ISEQ All Share index index by 0.52% after three consecutive losses for both. Possible explanations could include changes in market sentiment or news concerning this company that influenced this decline in their share price.

More news about BANK OF IR NCP STF (DD7D.IR).

Categories

stockMarket

Tags

Stock PricePrice DownMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketStockDD7D.IRBANK OF IR NCP STF
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com